Matthew Phipps
Stock Analyst at William Blair
(0)
# 4985
Out of 5,218 analysts
5
Total ratings
0.00%
Success rate
-36.92%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NuCana | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Aug 30, 2024 | |
Amgen | Upgrades: Outperform | n/a | n/a | n/a | 1 | May 3, 2024 | |
NewAmsterdam Pharma | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Dec 19, 2022 | |
Ikena Oncology | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Apr 20, 2021 | |
Pieris Pharmaceutica... | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jan 17, 2018 |